&#xa0;
[normal]&#xa0;
[normal]Executive Summary
[normal]&#xa0;[bold]•
[normal]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
[normal]The NFU recognises the importance of antimicrobial resistance as a fundamental threat to animals and humans 
[normal]alike.
[normal]&#xa0;
[normal]•
[normal]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
[normal]The NFU believes that antimicrobials are a precious resource and their effectiveness must be protected.
[normal]&#xa0;
[normal]•
[normal]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
[normal]Scientific evidence increasingly recognises that the problem of antimicrobial resistance in humans is a consequence of irresponsible use of 
[normal]antimicrobials in human medicine.
[normal]&#xa0;
[normal]•
[normal]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
[normal]Minimising the risk of disease on farm through the development and implementation of farm health planning and disease reduction strategies are an important aspect of reducing the need 
[normal]for
[normal] antimicrobials
[normal] on farm
[normal]. 
[normal]&#xa0;
[normal]•
[normal]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
[normal]Even wi
[normal]th the best of care however, farm animals will still get sick and may need antimicrobial treatment. 
[normal]These anti
[normal]microbials
[normal] are available only with a veterinary prescription and it is the veterinary surgeon who decides what to administer and when to use them.
[normal] The livestock keeper must ensure that these instructions are adhered to
[normal], as well as meeting regulatory commitments such as recording the use and treatment regime
[normal].
[normal]&#xa0;
[normal]•
[normal]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
[normal]The NFU fundamentally supports the principle of responsible use of antimicrobials which mea
[normal]ns using them as little as possible and as much as necessary.
[normal]&#xa0;
[normal]•
[normal]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
[normal]The NFU feels that 
[normal]the UK’s intervention strategy for reducing the impact and development of 
[normal]antimicrobial
[normal] resistance hinge
[normal]s
[normal] around identifying a
[normal]nd avoiding high risk practices, and believes th
[normal]at
[normal] this is where the responsible use principles
[normal], as developed and promoted by RUMA,
[normal] 
[normal]should be fully supported.
[normal]&#xa0;
[normal]•
[normal]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
[normal]The NFU is opposed to setting targets or level of use restrictions
[normal], as implemented in some other EU Member States
[normal]. Reducing dosages or the lengt
[normal]h of treatment simply to use a lesser quantity of anti
[normal]microbials
[normal] to meet reduction targets is not responsible use. It could in fact encourage the development of 
[normal]antimicrobial
[normal] resistance
[normal],
[normal] compro
[normal]mise animal health and welfare and encourage illegal practices.
[normal]&#xa0;
[normal]Introduction
[normal]&#xa0;[bold]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]How has antimicrobial resistance developed in the past decade?
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]What are the gaps in our knowledge about antimicrobial resistance?
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]Is there sufficient research and investment into new antibiotics or other treatments and methods to
[normal] ensure continued protection against infection? If not, how could this be rectified?
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]What measures (including behavioural change) have been most effective in controlling the spread of resistant pathogens, and could such measures be used to 
[normal]control other pathogens?
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]What global coordination and action is required to fight antimicrobial resistance and is the UK contributing enough towards cross-border initiatives?
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]What are the strengths and weaknesses of the Go
[normal]vernment’s 2013-2018 strategy for tackling antimicrobial resistance? What changes might be made to further strengthen the Government’s action plan?
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]&#xa0;
[normal]November 2013
[normal]&#xa0;
[normal]